Quantification of designer nuclease induced mutation rates: a direct comparison of different methods

by Eric Ehrke-Schulz, Thorsten Bergmann, Maren Schiwon, Johannes Doerner, Kamola Saydaminova, Andre Lieber, Anja Ehrhardt
Published 2016-01-01

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

by Maximilian Richter, Roma Yumul, Kamola Saydaminova, Hongjie Wang, Michael Gough, Audrey Baldessari, Roberto Cattaneo, Frank Lee, Chung-Huei Katherine Wang, Haishan Jang, Anne Astier, Ajay Gopal, Darrick Carter, André Lieber
Published 2016-01-01

Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin

by Maximilian Richter, Roma Yumul, Hongjie Wang, Kamola Saydaminova, Martin Ho, Drew May, Audrey Baldessari, Michael Gough, Charles Drescher, Nicole Urban, Steve Roffler, Chloé Zubieta, Darrick Carter, Pascal Fender, André Lieber
Published 2015-01-01

Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

by Kamola Saydaminova, Xun Ye, Hongjie Wang, Maximilian Richter, Martin Ho, HongZhuan Chen, Ning Xu, Jin-Soo Kim, Eirini Papapetrou, Michael C Holmes, Philip D Gregory, Donna Palmer, Philip Ng, Anja Ehrhardt, André Lieber
Published 2015-01-01